abstract |
This invention relates to compounds that are useful as inhibitors, in particular as inhibitors of Nicotinamide N-methyltransferase (NNMT), formulations composing such compounds. The compounds and formulations may be used as a medicament, for example in the treatment of 5 cancer, metabolic disease, or neurodegenerative disease. The compounds may be of formula |: |